Perspectives: How Should The US Prioritize Booster Shots?
Headline Roundup September 25th, 2021
Following the CDC's approval of a third shot of the Pfizer-BioNTech COVID-19 vaccine for those 65 and older or who are at high risk, many Americans remain divided on how the nation should administer booster shots moving forward. The U.S. has been taking notes from Israel's booster shot rollout that launched on Aug. 29, which made the third vaccine dose available for vaccinated individuals 12 and older. One study conducted at an Israeli hospital found that antibody counts in the body after a third dose were about 10 times higher than after a second dose. Israel said its booster shot strategy has helped combat the highly infectious Delta variant, and commended the U.S. for approving the shots for certain adults. “The main question now is of prioritization,” said Israeli public health official Dr. Nadav Davidovitch. After the World Health Organization called for a moratorium on booster shots until the end of the year to help other countries, some health officials across the globe have called for more evidence to justify giving booster shots to most Americans.
Voices across the spectrum questioned the booster shot rollout, but opinions diverged on how to administer them. Some right-rated voices believe that individuals "more at risk of severe illness should have the booster option" and that Americans should be prioritized before other nations. Some outlets noted how "it’s not a zero-sum game," suggesting that the U.S. can do both by ramping up vaccine production through "accelerated technology" and utilizing international alliances. Left-rated outlets were more likely to highlight criticism from the scientific community that points to the "extreme global vaccine inequity." Some also fear that the CDC's narrowing of Biden's initial plan will result in more vaccine hesitancy across the country.
The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) this week shared recommendations for COVID-19 vaccine booster shots, which — alongside mandates to boost vaccination rates — will help get the pandemic back under control as the second COVID-19 winter looms.
These recommendations — and the underlying evidence of vaccine effectiveness and durability — are good news more or less across the board, despite the concerns of those who oppose boosters so long as global vaccination rates remain low.
The FDA and CDC drew...
Earlier the World Health Organization set a goal of having at least 10 percent of every country‘s population vaccinated against COVID-19 by the end of this month. It aimed to then raise that figure to 40 percent by the end of the year and to 70 percent by the middle of 2022.
Sadly, these targets have little chance of being met. Of the more than 5.8 billion doses of COVID vaccines that have been administered across the world by mid-September, the vast majority (about 80 percent) have gone to people...
While Israel’s seen dynamite data from its third vaccine shots and England is set to follow suit, America could be held hostage to a brewing Beltway booster battle.
The Food and Drug Administration just refused to recommend approval of Pfizer’s application to give the general public third COVID-vaccine doses. Team Biden wants to start its booster campaign next week — but doesn’t seem willing to shake the FDA out of its return to business-as-usual hypercaution to do it.
The FDA released a report Wednesday — two days before an outside panel considers Pfizer’s request...
AllSides Talks: Political Stereotypes
Monday, October 25, 2021, 5PM PT / 8PM ET
This Monday, Americans from across the political spectrum will meet in small groups to explore the impact of political stereotypes, and what they wish others would understand about their beliefs.